Status:

UNKNOWN

Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease.

Lead Sponsor:

Professor Lu Neurological Clinic

Conditions:

Parkinson Disease

Eligibility:

All Genders

45-80 years

Phase:

NA

Brief Summary

This RCT study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific ...

Detailed Description

This RCT study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific ...

Eligibility Criteria

Inclusion

  • Modified Hoehn \&Yahr stage, MHY 1-3
  • 45-80 years old
  • at least 9 years education

Exclusion

  • Patients on antibiotics within the preceding one month
  • Patients using of other probiotic products (sachet, capsule or tablet) within the preceding two weeks
  • Have undergone surgery of liver, bladder, or gastrointestinal tract
  • Have current or history of inflammatory bowel disease
  • Have history of cancer
  • Known allergy to probiotics
  • Patients with comorbid dementia (Mini-Mental State Examination score ≤ 26) or major depression (The Beck Depression Inventory-II score ≥ 29)
  • Have received deep brain stimulation
  • Patients receiving artificial enteral or intravenous nutrition
  • Diagnosed before 40 years old
  • Poor control of other chronic diseases
  • Not eligible judged by PI

Key Trial Info

Start Date :

July 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2023

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT04722211

Start Date

July 6 2020

End Date

June 30 2023

Last Update

January 25 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Professor Lu Neurological Clinic

Taoyuan, Guishan Dist., Taiwan, 333